Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daly

Showing results (321-330 of 397) with videos related to

Pageof 40
Sort By:
Blood|October 20, 2011
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among childrenTina T Biss, Peter J Avery, Leonardo R Brandão, et al.
British Journal of Clinical Pharmacology|June 23, 2011
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsSteven Lane, Sameh Al-Zubiedi, Ellen Hatch, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.
Genes|October 28, 2023
Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell DiseaseMohammad A Alshabeeb, Deemah Alwadaani, Farjah H Al Qahtani, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Nature Medicine|September 8, 2020
Polygenic architecture informs potential vulnerability to drug-induced liver injuryMasaru Koido, Eri Kawakami, Junko Fukumura, et al.
International Journal of Cardiology|September 6, 2014
Heart rate awareness in patients with chronic stable heart failure. A multi-center observational studyD Moran, A Buckley, K Daly, et al.
Journal of Hepatology|March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinomaY-L Liu, G L Patman, J B S Leathart, et al.
Pageof 40

Showing results (321-330 of 397) with videos related to

Sort By:
Pageof 40
Blood|October 20, 2011
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among childrenTina T Biss, Peter J Avery, Leonardo R Brandão, et al.
British Journal of Clinical Pharmacology|June 23, 2011
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsSteven Lane, Sameh Al-Zubiedi, Ellen Hatch, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.
Genes|October 28, 2023
Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell DiseaseMohammad A Alshabeeb, Deemah Alwadaani, Farjah H Al Qahtani, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Nature Medicine|September 8, 2020
Polygenic architecture informs potential vulnerability to drug-induced liver injuryMasaru Koido, Eri Kawakami, Junko Fukumura, et al.
International Journal of Cardiology|September 6, 2014
Heart rate awareness in patients with chronic stable heart failure. A multi-center observational studyD Moran, A Buckley, K Daly, et al.
Journal of Hepatology|March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinomaY-L Liu, G L Patman, J B S Leathart, et al.
Pageof 40